Cargando…

Modulation of β-Catenin Signaling by Glucagon Receptor Activation

The glucagon receptor (GCGR) is a member of the class B G protein–coupled receptor family. Activation of GCGR by glucagon leads to increased glucose production by the liver. Thus, glucagon is a key component of glucose homeostasis by counteracting the effect of insulin. In this report, we found that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Jiyuan, Zhang, Chenghai, Harikumar, Kaleeckal G., Zylstra-Diegel, Cassandra R., Wang, Liren, Mowry, Laura E., Miller, Laurence J., Williams, Bart O., Xu, H. Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306284/ https://www.ncbi.nlm.nih.gov/pubmed/22438981 http://dx.doi.org/10.1371/journal.pone.0033676

Ejemplares similares

Wnt/β-catenin Signaling in Normal and Cancer Stem Cells
por: Valkenburg, Kenneth C., et al.
Publicado: (2011)

β-catenin-dependent High Bone Mass Induced by Loss of APC in Osteoblasts Does Not Require Lrp5 or Lrp6
por: Diegel, Cassandra R., et al.
Publicado: (2023)

Structure and function of Norrin in assembly and activation of a Frizzled 4–Lrp5/6 complex
por: Ke, Jiyuan, et al.
Publicado: (2013)

Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity
por: Dengler, Daniela G., et al.
Publicado: (2022)

Wnt5a promotes Frizzled-4 signalosome assembly by stabilizing cysteine-rich domain dimerization
por: DeBruine, Zachary J., et al.
Publicado: (2017)

Mechanism of Action and Structure–Activity Relationships of Tetracyclic Small Molecules Acting as Universal Positive Allosteric Modulators of the Cholecystokinin Receptor
por: Dengler, Daniela G., et al.
Publicado: (2023)

Spatial intensity distribution analysis quantifies the extent and regulation of homodimerization of the secretin receptor
por: Ward, Richard J., et al.
Publicado: (2017)

Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics
por: Miller, Laurence J., et al.
Publicado: (2021)

Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the γ-secretase cleavage sites
por: Yan, Yan, et al.
Publicado: (2017)

Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus
por: Ng, Hans K. H., et al.
Publicado: (2016)

The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development
por: Lindvall, Charlotta, et al.
Publicado: (2009)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis
por: Song, Xiaowen, et al.
Publicado: (2015)

Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice
por: Wei, Tianjiao, et al.
Publicado: (2023)

Hepatocyte cholesterol content modulates glucagon receptor signalling
por: McGlone, Emma Rose, et al.
Publicado: (2022)

Environment-Sensitive Fluorescence of 7-Nitrobenz-2-oxa-1,3-diazol-4-yl (NBD)-Labeled Ligands for Serotonin Receptors
por: Sarkar, Parijat, et al.
Publicado: (2021)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

Mutation of the galectin‐3 glycan‐binding domain ( Lgals3‐R200S) enhances cortical bone expansion in male mice and trabecular bone mass in female mice
por: Maupin, Kevin A., et al.
Publicado: (2022)

The Glycosphingolipid GM3 Modulates Conformational Dynamics of the Glucagon Receptor
por: Ansell, T. Bertie, et al.
Publicado: (2020)

Modulating effects of RAMPs on signaling profiles of the glucagon receptor family
por: Shao, Lijun, et al.
Publicado: (2022)

Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol
por: Harikumar, Kaleeckal G., et al.
Publicado: (2021)

Embryonic Stem Cell Differentiation Is Regulated by SET through Interactions with p53 and β-Catenin
por: Harikumar, Arigela, et al.
Publicado: (2020)

WNT7A Overexpression Inhibits Growth and Migration of Hepatocellular Carcinoma via the β-Catenin Independent Pathway
por: Lan, Lihui, et al.
Publicado: (2019)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)
por: Weston, Cathryn, et al.
Publicado: (2015)

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
por: Pocai, Alessandro, et al.
Publicado: (2009)

Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor
por: Cong, Zhaotong, et al.
Publicado: (2021)

Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles
por: Bueno, Ana B., et al.
Publicado: (2016)

Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction
por: Ali, Safina, et al.
Publicado: (2014)

Potent Prearranged Positive Allosteric Modulators of the Glucagon‐like Peptide‐1 Receptor
por: Jones, Ben J., et al.
Publicado: (2017)

Amyloid precursor protein modulates β-catenin degradation
por: Chen, Yuzhi, et al.
Publicado: (2007)

Modulating PKCα Activity to Target Wnt/β-Catenin Signaling in Colon Cancer
por: Dupasquier, Sébastien, et al.
Publicado: (2019)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
por: Madan, Babita, et al.
Publicado: (2018)

Glucagon-like Peptide-1 Receptor Analogues for the Treatment of Obesity
por: Williams, David M, et al.
Publicado: (2022)

Stabilisation of β-Catenin Downstream of T Cell Receptor Signalling
por: Lovatt, Matthew, et al.
Publicado: (2010)

Glucagon Receptor Signaling and Lipid Metabolism
por: Galsgaard, Katrine D., et al.
Publicado: (2019)

Glucagon and Its Receptors in the Mammalian Heart
por: Neumann, Joachim, et al.
Publicado: (2023)

Tail engagement of arrestin at the glucagon receptor
por: Chen, Kun, et al.
Publicado: (2023)

Recent Progress in the Use of Glucagon and Glucagon Receptor Antago-nists in the Treatment of Diabetes Mellitus
por: Lotfy, Mohamed, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1marv5rtr9325tgp8ilsoup84c